Fund 1 Investments, LLC Delivered A Letter To Lionel F. Conacher, Chairman Of Board Of The Destination XL Group, Inc.

13D weekly report - Dec 16, 2024 to Dec 20, 2024

Goodwood Inc. Targets COSCIENS Biopharma (CSCI) Over Cash Burn, Weak Strategy, and Board Accountability

COSCIENS Biopharma (CSCI): Goodwood Inc. Presses for Board Overhaul, Criticizes R&D Spending and Governance

Goodwood Inc. Demands Strategic Overhaul and Board Restructuring at COSCIENS Biopharma Inc (CSCI)

Goodwood Inc. Sent A Letter To Cosciens Biopharma Inc.

180 Degree Capital Corporation (TURN) and Mount Logan Capital complete merger

Marlton Partners nominated Board candidates to 180 Degree Capital Corporation (TURN)

Lamb Weston (LW): JANA Partners Urges Board and Leadership Overhaul, Warns Sale Should Be Considered

JANA Partners Sends Letter to Board of Directors of Lamb Weston Holdings

Marlton Partners Challenges 180 Degree Capital (TURN) Board, Urges Capital Return Plan to Eliminate NAV Discount

180 Degree Capital (TURN): Marlton Partners Nominates Directors, Criticizes Kevin Rendino for Value Destruction and NAV Discount

Marlton Partners Pushes for Board Change at 180 Degree Capital (TURN), Citing -37% NAV Decline and Governance Failures

Marlton Partners L.P. Open Letter to Shareholders of 180 Degree Capital Corp.

Radoff reaches agreement with Atea Pharmaceuticals, Inc (AVIR)